• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

6
5
5
5
2

COUNTRY

1
1
1
1
1

CATEGORIES

  • 12
  • 12
  • 3
  • 1
  • 1

PRICE

2
2
2
28

PUBLISHED

0
2
12
28

PRODUCT TYPE

27
1

Search "Paladin Labs Inc.-Therapeutic Competitors Report" returned 28 results.

PRODUCT TITLE
Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others - Product Thumbnail Image

Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in managing pancreatic cancer drug development Find out whether you are number one, two or further down the ladder...

March 2012
FROM

Antidepressants Market to 2018 - Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs) Continue to Dominate in the Absence of Effective Therapeutic Alternatives

GBI Research, the leading business intelligence provider, has released its latest research, “Antidepressants Market to 2018 - Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs)...

October 2012
FROM

Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020” The report is an essential...

December 2010
FROM

Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020” The report is an essential...

December 2010
FROM

Prostate Cancer - France Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - France Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - France Drug Forecasts and Treatment Analysis to 2020” is an essential source...

December 2010
FROM

Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020” is an essential source...

December 2010
FROM

Acromegaly - Pipeline Review, H1 2014

Acromegaly - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Acromegaly - Pipeline Review, H1 2014’, provides an overview of the Acromegaly’s therapeutic pipeline. This report provides...

March 2014
FROM

Prostate Cancer - Germany Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - Germany Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Germany Drug Forecasts and Treatment Analysis to 2020” The report is an...

November 2010
FROM

Low Back Pain - Pipeline Review, H2 2014

Low Back Pain - Pipeline Review, H2 2014 Summary This, ‘Low Back Pain - Pipeline Review, H2 2014’, provides an overview of the Low Back Pain’s therapeutic pipeline. This report provides comprehensive...

November 2014
FROM

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014 Summary This, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014’, provides an overview of the Peripheral...

August 2014
FROM

AlphaRx, Inc. (ALRX) - Financial and Strategic SWOT Analysis Review

Summary AlphaRX, Inc. (AlphaRx), formerly known as Logic Tech International Inc., is a specialty pharmaceutical company. It undertakes focuses on the development of novel therapeutic products to treat...

January 2013
FROM

Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Brazil, Russia, India and China (BRIC) Drug Forecasts and Treatment Analysis...

December 2010
FROM

Prostate Cancer - UK Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - UK Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - UK Drug Forecasts and Treatment Analysis to 2020” is an essential source of information...

November 2010
FROM

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2014

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2014 Summary This, ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2014’, provides an overview of the Chemotherapy...

December 2014
FROM

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015 Summary This ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Chemotherapy...

February 2015
FROM

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2014

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2014’, provides an overview...

March 2014
FROM

Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010

Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010 Summary Our pharmaceutical report, “Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010”...

November 2010
FROM

Acute Pain - Pipeline Review, H2 2014

Acute Pain - Pipeline Review, H2 2014 Summary This, ‘Acute Pain - Pipeline Review, H2 2014’, provides an overview of the Acute Pain’s therapeutic pipeline. This report provides comprehensive information...

July 2014
FROM

Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020” is an essential source of information...

December 2010
FROM

Migraine - Pipeline Review, H1 2014

Migraine - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Migraine - Pipeline Review, H1 2014’, provides an overview of the Migraine’s therapeutic pipeline. This report provides comprehensive...

February 2014
FROM
Loading Indicator

Our Clients

Ikea Systems B.V. GlaxoSmithKline PLC BT Group PLC. Philips N.V. BSH Home Appliances Ltd Foreign & Commonwealth Office